PE42295A1 - Preparacion farmaceutica con un elemento activo y un sistema efervescente asi como metodo para la elaboracion de la preparacion - Google Patents

Preparacion farmaceutica con un elemento activo y un sistema efervescente asi como metodo para la elaboracion de la preparacion

Info

Publication number
PE42295A1
PE42295A1 PE1995271312A PE27131295A PE42295A1 PE 42295 A1 PE42295 A1 PE 42295A1 PE 1995271312 A PE1995271312 A PE 1995271312A PE 27131295 A PE27131295 A PE 27131295A PE 42295 A1 PE42295 A1 PE 42295A1
Authority
PE
Peru
Prior art keywords
preparation
pct
effervescent system
well
active element
Prior art date
Application number
PE1995271312A
Other languages
English (en)
Inventor
Gerhard Gergely
Thomas Gergely
Irmgard Gergely
Original Assignee
Gerhard Gergely
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerhard Gergely filed Critical Gerhard Gergely
Publication of PE42295A1 publication Critical patent/PE42295A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

CARACTERIZADA POR COMPRENDER: 1) UN PRINCIPIO ACTIVO HIDROFOBICO TAL COMO LORATADINA O CISAPRIDA; 2) UN TENSOACTIVO TAL COMO DOCUSATO DE SODIO O LAURILSULFATO DE SODIO Y UN EMULSIONANTE ELEGIDO DEL GRUPO DE LOS ESTERES SACARIDOS, DE LOS POLISORBATOS Y DE LOS FOSFOLIPIDOS, QUE PUEDE ESTAR DEPOSITADO SOBRE LOS GRANULOS ; 3) UN SISTEMA EFERVESCENTE; DICHA COMPOSICION SE ENCUENTRA EN FORMA DE GRANULOS TALES COMO: A) UN GRANULO DE PRINCIPIO ACTIVO FORMADO CON LA AYUDA DE UN AGLUTINANTE COMO POLIVINILPIRROLIDINA SOBRE LA SUPERFICIE DE UNA SUSTANCIA EN SUSPENSION TAL COMO CELULOSA MICROCRISTALINA, QUE ADEMAS PUEDE CONTENER UN COMPONENTE EFERVESCENTE Y/O UNA SUSTANCIA DE CARGA; B) GRANULOS PARA EL SISTEMA EFERVESCENTE; C) GRANULOS PARA EL EMULSIONANTE; TENIENDO COMO VENTAJAS FACILIDAD EN LA DISOLUCION, MENOR FORMACION DE UN CAPA SOBRENADANTE INDESEABLE Y MENOR FORMACION DE ESPUMA
PE1995271312A 1994-06-15 1995-06-14 Preparacion farmaceutica con un elemento activo y un sistema efervescente asi como metodo para la elaboracion de la preparacion PE42295A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH01890/94A CH686865A5 (de) 1994-06-15 1994-06-15 Pharmazeutische Zubereitung mit einem hydrophoben Wirkstoff und einem Brausesystem, sowie Verfahren zur Herstellung der Zubereitung.

Publications (1)

Publication Number Publication Date
PE42295A1 true PE42295A1 (es) 1995-12-28

Family

ID=4221002

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1995271312A PE42295A1 (es) 1994-06-15 1995-06-14 Preparacion farmaceutica con un elemento activo y un sistema efervescente asi como metodo para la elaboracion de la preparacion

Country Status (26)

Country Link
US (1) US5834019A (es)
EP (1) EP0768868B1 (es)
JP (1) JPH10501535A (es)
KR (1) KR100367302B1 (es)
CN (1) CN1149071C (es)
AT (1) ATE204744T1 (es)
AU (1) AU684966B2 (es)
BR (1) BR9508002A (es)
CA (1) CA2191302C (es)
CH (1) CH686865A5 (es)
CO (1) CO4410175A1 (es)
CZ (1) CZ287807B6 (es)
DE (1) DE59509566D1 (es)
ES (1) ES2161901T3 (es)
HU (1) HU221680B1 (es)
IL (1) IL114144A (es)
MX (1) MX9606391A (es)
MY (1) MY113718A (es)
NO (1) NO314016B1 (es)
NZ (1) NZ288208A (es)
PE (1) PE42295A1 (es)
PL (1) PL180135B1 (es)
SK (1) SK281262B6 (es)
TW (1) TW457097B (es)
WO (1) WO1995034284A1 (es)
ZA (1) ZA954932B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69713948D1 (de) * 1996-04-23 2002-08-22 Janssen Pharmaceutica Nv Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
EP0803251B1 (en) * 1996-04-23 2002-07-17 Janssen Pharmaceutica N.V. Immediate release pH-independent solid dosage form of cisapride
KR20010012104A (ko) * 1997-06-11 2001-02-15 디르크 반테 (+)- 또는 (-)-시사프라이드의 즉시 방출 ｐＨ-비의존적 고체 제형
WO2002085337A1 (en) 2001-04-20 2002-10-31 The University Of British Columbia Micellar drug delivery systems for hydrophobic drugs
US6589555B2 (en) 1999-12-29 2003-07-08 Mahendra Pandya Effervescent vitaceutical compositions and related methods
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
CA2440935A1 (en) * 2001-03-13 2002-09-19 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
US20030157170A1 (en) * 2001-03-13 2003-08-21 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
JP2005506990A (ja) * 2001-10-19 2005-03-10 アイソテクニカ インコーポレーテッド 新規のシクロスポリン類似体のマイクロエマルションプレコンセントレート
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20050069590A1 (en) * 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
CN100381123C (zh) * 2005-01-12 2008-04-16 南京亿华药业有限公司 一种氯雷他定颗粒剂及其制法
CN101897732B (zh) * 2009-05-27 2013-01-30 北京因科瑞斯医药科技有限公司 一种中药泡腾片剂及其制备方法
CN106236713B (zh) * 2016-08-30 2018-11-09 林州中农颖泰生物肽有限公司 一种七清败毒泡腾颗粒及其制备方法
CN107296800A (zh) * 2017-06-01 2017-10-27 江苏黄河药业股份有限公司 一种氯雷他定泡腾片及其制备方法
CN112741841A (zh) * 2019-10-29 2021-05-04 湖北真奥医药研究院有限公司 三维钙自乳化泡腾剂组合物及其制剂的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3584522D1 (de) * 1984-12-14 1991-11-28 Gergely Gerhard Teilchen aus einer hydrophoben oder schwerloeslichen substanz und verfahren zu ihrer hydrophilisierung.
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs

Also Published As

Publication number Publication date
CH686865A5 (de) 1996-07-31
EP0768868A1 (de) 1997-04-23
ES2161901T3 (es) 2001-12-16
MX9606391A (es) 1997-07-31
US5834019A (en) 1998-11-10
MY113718A (en) 2002-05-31
PL317856A1 (en) 1997-04-28
EP0768868B1 (de) 2001-08-29
NO314016B1 (no) 2003-01-20
IL114144A (en) 1999-07-14
KR100367302B1 (ko) 2003-04-16
SK159396A3 (en) 1997-08-06
BR9508002A (pt) 2000-05-30
HUT75674A (en) 1997-05-28
CA2191302C (en) 2010-08-10
ZA954932B (en) 1996-02-07
NO965244L (no) 1997-02-13
PL180135B1 (pl) 2000-12-29
CO4410175A1 (es) 1997-01-09
DE59509566D1 (de) 2001-10-04
TW457097B (en) 2001-10-01
ATE204744T1 (de) 2001-09-15
AU2749795A (en) 1996-01-05
HU221680B1 (hu) 2002-12-28
NZ288208A (en) 1998-08-26
KR970703131A (ko) 1997-07-03
WO1995034284A1 (de) 1995-12-21
NO965244D0 (no) 1996-12-09
CN1149071C (zh) 2004-05-12
JPH10501535A (ja) 1998-02-10
CZ287807B6 (en) 2001-02-14
CN1151693A (zh) 1997-06-11
IL114144A0 (en) 1995-10-31
CZ367296A3 (en) 1997-04-16
SK281262B6 (sk) 2001-01-18
AU684966B2 (en) 1998-01-08
CA2191302A1 (en) 1995-12-21
HU9603452D0 (en) 1997-02-28

Similar Documents

Publication Publication Date Title
PE42295A1 (es) Preparacion farmaceutica con un elemento activo y un sistema efervescente asi como metodo para la elaboracion de la preparacion
EE200100660A (et) Ravimvorm happe suhtes labiilsete toimeainete jaoks, toimeaine üksus, selle valmistamismeetod ja mikrokerake
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
CA2330330A1 (en) Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug
MX27046A (es) 5-arilalquil-4-alcoxy-2(5h)-furanonas, productos intermedios y procedimiento para su preparacion asi como su aplicacion como sustancia activa terapeutica.
DE59602775D1 (de) 6-Dimethylaminomethyl-1-phenyl-cyclo-hexanverbindungen als pharmazeutische Wirkstoffe
DE59604226D1 (de) 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-olverbindungen als pharmazeutische Wirkstoffe
AU6171796A (en) Prodrugs of pharmaceuticals with improved bioavailability
FR2774288B1 (fr) Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques
PT973506E (pt) Processo para preparacao de formas de dosagem farmaceuticas solidas
SE9704401D0 (sv) Matrix pellets for greasy, oily or sticky drug substances
ES2070131T5 (es) Sistemas de farmaco-lipido de baja toxicidad.
ATE122882T1 (de) Antiphlogistisches mittel.
HUP9602678A1 (en) 13-substituted milbemycin 5-oxime derivatives, use thereof, anthelmintic, acaricide and insecticide compositions containing these compounds as active ingredients
BR9913782A (pt) Processo de preparação de uma formualação galênica que compreende fenofibrato como princìpio ativo, formulação galênica, medicamento e utilizações de um meio lìquido e de partìculas de fenofibrato
BR9404225A (pt) Formulação de substância ativa, aplicação, composições, medicamentos e processo para a preparação das formulações
RU94040150A (ru) Стабильная лиофилизированная композиция тиотепа, способ ее получения
ES2144154T3 (es) Derivados de eritromicina a 9-0-oxima dotados de actividad antibiotica.
TR199903272T2 (xx) Ast�m kar��t� ila�lar�n yeni bile�imleri.
SE8302580D0 (sv) Substituerade iminoderivat av dihydrobensopyran och dihydrobensotiopyran och forfarande for deras framstellning
ATE234096T1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
IT1185523B (it) Derivati di nitrodiarilsolfossidi,procedimento per la loro preparazione e composizioni farmaceutiche e pesticide che li contengono come ingrediente attivo
ITMI930273A0 (it) Composti terapeuticamente attivi, utili per il trattamento di malattie connesse con alterata funzionalita' del sistema immunitario procedimento per la loro preparazione e composizione farmaceutiche che li contengono
MX9304449A (es) Compuestos quimicos.
UY24489A1 (es) Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimiento para su preparación y aplicación de estos compuestos en medicamentos.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal